BioNote Statistics

Total Valuation

BioNote has a market cap or net worth of KRW 486.81 billion. The enterprise value is 89.55 billion.

Market Cap	486.81B
Enterprise Value	89.55B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

BioNote has 102.06 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class	n/a
Shares Outstanding	102.06M
Shares Change (YoY)	+1.91%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	61.10%
Owned by Institutions (%)	0.19%
Float	11.74M

Valuation Ratios

The trailing PE ratio is 12.10.

PE Ratio	12.10
Forward PE	n/a
PS Ratio	4.88
PB Ratio	0.31
P/TBV Ratio	0.31
P/FCF Ratio	14.99
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.54, with an EV/FCF ratio of 2.76.

EV / Earnings	2.22
EV / Sales	0.90
EV / EBITDA	4.54
EV / EBIT	7.76
EV / FCF	2.76

Financial Position

The company has a current ratio of 33.58, with a Debt / Equity ratio of 0.00.

Current Ratio	33.58
Quick Ratio	31.67
Debt / Equity	0.00
Debt / EBITDA	0.20
Debt / FCF	0.12
Interest Coverage	45.49

Financial Efficiency

Return on equity (ROE) is 2.56% and return on invested capital (ROIC) is 0.46%.

Return on Equity (ROE)	2.56%
Return on Assets (ROA)	0.44%
Return on Capital (ROIC)	0.46%
Revenue Per Employee	334.92M
Profits Per Employee	135.42M
Employee Count	298
Asset Turnover	0.06
Inventory Turnover	1.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.53%
50-Day Moving Average	4,679.30
200-Day Moving Average	4,426.03
Relative Strength Index (RSI)	54.18
Average Volume (20 Days)	95,190

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNote had revenue of KRW 99.81 billion and earned 40.35 billion in profits. Earnings per share was 394.18.

Revenue	99.81B
Gross Profit	48.36B
Operating Income	11.54B
Pretax Income	-28.86B
Net Income	40.35B
EBITDA	19.72B
EBIT	11.54B
Earnings Per Share (EPS)	394.18

Full Income Statement

Balance Sheet

The company has 401.10 billion in cash and 3.85 billion in debt, giving a net cash position of 397.25 billion or 3,892.50 per share.

Cash & Cash Equivalents	401.10B
Total Debt	3.85B
Net Cash	397.25B
Net Cash Per Share	3,892.50
Equity (Book Value)	1.59T
Book Value Per Share	15,574.49
Working Capital	437.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.92 billion and capital expenditures -8.44 billion, giving a free cash flow of 32.48 billion.

Operating Cash Flow	40.92B
Capital Expenditures	-8.44B
Free Cash Flow	32.48B
FCF Per Share	318.26

Full Cash Flow Statement

Margins

Gross margin is 48.46%, with operating and profit margins of 11.56% and 40.43%.

Gross Margin	48.46%
Operating Margin	11.56%
Pretax Margin	-28.91%
Profit Margin	40.43%
EBITDA Margin	19.76%
EBIT Margin	11.56%
FCF Margin	32.54%

Dividends & Yields

BioNote does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	50.58%
Buyback Yield	-1.91%
Shareholder Yield	-1.91%
Earnings Yield	8.26%
FCF Yield	6.67%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNote has an Altman Z-Score of 7.92.

Altman Z-Score	7.92
Piotroski F-Score	n/a